Norifumi Tsukamoto

4.4k total citations
139 papers, 2.1k citations indexed

About

Norifumi Tsukamoto is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Norifumi Tsukamoto has authored 139 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 45 papers in Pathology and Forensic Medicine and 40 papers in Genetics. Recurrent topics in Norifumi Tsukamoto's work include Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (20 papers). Norifumi Tsukamoto is often cited by papers focused on Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (20 papers). Norifumi Tsukamoto collaborates with scholars based in Japan, United States and Nigeria. Norifumi Tsukamoto's co-authors include Hirokazu Murakami, Hiroshi Handa, Yoshihisa Nojima, Akihiko Yokohama, Masamitsu Karasawa, Takayuki Saitoh, Takafumi Matsushima, Kimio Morita, Hatsue Ogawara and Hiromi Koiso and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Norifumi Tsukamoto

132 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norifumi Tsukamoto Japan 25 826 706 561 440 433 139 2.1k
Shin Fujisawa Japan 27 1.1k 1.3× 410 0.6× 561 1.0× 293 0.7× 572 1.3× 182 2.2k
Piero Galieni Italy 26 739 0.9× 700 1.0× 564 1.0× 275 0.6× 706 1.6× 89 1.7k
Judit Demeter Hungary 18 426 0.5× 553 0.8× 562 1.0× 269 0.6× 413 1.0× 117 1.6k
Anna Porwit‐MacDonald Sweden 30 1.1k 1.4× 938 1.3× 631 1.1× 436 1.0× 604 1.4× 50 2.7k
Anne Lennard United Kingdom 20 414 0.5× 831 1.2× 562 1.0× 240 0.5× 561 1.3× 51 1.6k
Bruno Royer France 27 1.1k 1.3× 414 0.6× 741 1.3× 342 0.8× 623 1.4× 84 2.5k
Benet Nomdedeu Spain 22 881 1.1× 592 0.8× 829 1.5× 285 0.6× 349 0.8× 88 1.8k
Ester Orlandi Italy 26 1.2k 1.5× 771 1.1× 1.3k 2.3× 218 0.5× 546 1.3× 95 2.4k
Ho‐Jin Shin South Korea 22 944 1.1× 691 1.0× 365 0.7× 412 0.9× 655 1.5× 182 2.0k
Alexander Claviez Germany 26 343 0.4× 836 1.2× 441 0.8× 206 0.5× 751 1.7× 80 2.1k

Countries citing papers authored by Norifumi Tsukamoto

Since Specialization
Citations

This map shows the geographic impact of Norifumi Tsukamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norifumi Tsukamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norifumi Tsukamoto more than expected).

Fields of papers citing papers by Norifumi Tsukamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norifumi Tsukamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norifumi Tsukamoto. The network helps show where Norifumi Tsukamoto may publish in the future.

Co-authorship network of co-authors of Norifumi Tsukamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Norifumi Tsukamoto. A scholar is included among the top collaborators of Norifumi Tsukamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norifumi Tsukamoto. Norifumi Tsukamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ri, Masaki, Shinsuke Iida, Dai Maruyama, et al.. (2021). HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1). Cancer Science. 112(12). 5011–5019. 3 indexed citations
2.
Kobayashi, Nobuhiko, Tsukasa Oda, Makiko Takizawa, et al.. (2020). Integrin α7 and Extracellular Matrix Laminin 211 Interaction Promotes Proliferation of Acute Myeloid Leukemia Cells and Is Associated with Granulocytic Sarcoma. Cancers. 12(2). 363–363. 14 indexed citations
3.
Iida, Shinsuke, Masashi Wakabayashi, Kunihiro Tsukasaki, et al.. (2018). Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma. Cancer Science. 109(5). 1552–1561. 5 indexed citations
4.
Kasamatsu, Tetsuhiro, Noriyuki Takahashi, Nanami Gotoh, et al.. (2018). PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia. British Journal of Haematology. 180(5). 705–714. 26 indexed citations
5.
Koiso, Hiromi, Akihiko Yokohama, Takeki Mitsui, et al.. (2012). Follicular Lymphoma Presenting with Marked Splenomegaly: Report of Three Cases. Acta Haematologica. 128(1). 47–52. 3 indexed citations
6.
Yokohama, Akihiko, Hirotaka Nakahashi, Takeki Mitsui, et al.. (2011). TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients. International Journal of Hematology. 95(1). 77–85. 5 indexed citations
7.
Shimada, Kazuyuki, Takuhei Murase, Kosei Matsue, et al.. (2010). Central nervous system involvement in intravascular large B‐cell lymphoma: A retrospective analysis of 109 patients. Cancer Science. 101(6). 1480–1486. 80 indexed citations
8.
Tobinai, Kensei, Takashi Watanabe, Michinori Ogura, et al.. (2009). Japanese phase II study of 90Y‐ibritumomab tiuxetan in patients with relapsed or refractory indolent B‐cell lymphoma. Cancer Science. 100(1). 158–164. 24 indexed citations
9.
Saitoh, Takayuki, Takafumi Matsushima, Yasuyuki Saito, et al.. (2008). Hodgkin Lymphoma Presenting with Various Immunologic Abnormalities, Including Autoimmune Hepatitis, Hashimoto's Thyroiditis, Autoimmune Hemolytic Anemia, and Immune Thrombocytopenia. Clinical Lymphoma & Myeloma. 8(1). 62–64. 10 indexed citations
10.
Tsukamoto, Norifumi, Masaru Kojima, Toshimasa Uchiyama, et al.. (2007). Primary cutaneous CD5+ marginal zone B‐cell lymphoma resembling the plasma cell variant of Castleman's disease. Apmis. 115(12). 1426–1431. 10 indexed citations
11.
Saitoh, Takayuki, Takafumi Matsushima, Arito Yamane, et al.. (2007). Hodgkin Lymphoma Accompanied by Aplastic Anemia and Polyclonal Expansion of Large Granular Lymphocytes. Acta Haematologica. 117(4). 238–241. 2 indexed citations
12.
Okada, Yuko, Katsunori Nakamura, Tetsuya Nakamura, et al.. (2005). Genotyping of Thiopurine Methyltransferase Using Pyrosequencing. Biological and Pharmaceutical Bulletin. 28(4). 677–681. 10 indexed citations
13.
Ogawara, Hatsue, Hiroshi Handa, Tohru Yamazaki, et al.. (2004). High Th1/Th2 ratio in patients with multiple myeloma. Leukemia Research. 29(2). 135–140. 74 indexed citations
14.
Karasawa, Masamitsu, Takeki Mitsui, Atsushi Isoda, et al.. (2003). TCR Vβ repertoire analysis in CD56+ CD16dim/− T‐cell large granular lymphocyte leukaemia: association with CD4 single and CD4/CD8 double positive phenotypes. British Journal of Haematology. 123(4). 613–620. 8 indexed citations
15.
Murakami, Hirokazu, Hideki Uchiumi, Nahoko Hatsumi, et al.. (2002). Steroid‐refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection. European Journal Of Haematology. 68(1). 49–53. 38 indexed citations
16.
Isoda, Atsushi, Akihiko Yokohama, Takafumi Matsushima, et al.. (2002). The naive T‐lymphocyte compartment is well preserved in patients with chronic myelogenous leukaemia in chronic phase. British Journal of Haematology. 119(4). 949–955. 11 indexed citations
17.
Karasawa, Masamitsu, Norifumi Tsukamoto, Kiyoshi Okamoto, et al.. (1999). Clinical Outcome in Three Patients with Myelodysplastic Syndrome Showing Polyclonal Hematopoiesis. Acta Haematologica. 101(1). 46–49. 5 indexed citations
18.
Tsukamoto, Norifumi, James Chen, & Akira Yoshida. (1998). Enhanced Expressions of Glucose-6-Phosphate Dehydrogenase and Cytosolic Aldehyde Dehydrogenase and Elevation of Reduced Glutathione Level in Cyclophosphamide-Resistant Human Leukemia Cells. Blood Cells Molecules and Diseases. 24(2). 231–238. 23 indexed citations
19.
Karasawa, Masamitsu, Kiyoshi Okamoto, Tadashi Maehara, et al.. (1996). Detection of c-myc oncogene amplification in a CML blastic phase patient with double minute chromosomes. Leukemia Research. 20(1). 85–91. 14 indexed citations
20.
Tsukamoto, Norifumi, Kimio Morita, Tadashi Maehara, et al.. (1992). Ki-1-Positive Large-Cell Anaplastic Lymphoma with Protean Manifestations Including Central Nervous System Involvement. Acta Haematologica. 88(2-3). 147–150. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026